HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael P Manos Selected Research

Michael P Manos Research Topics

Disease

12Neoplasms (Cancer)
11/2023 - 01/2017
9Melanoma (Melanoma, Malignant)
04/2024 - 01/2017
2Neoplasm Metastasis (Metastasis)
01/2022 - 10/2021
1Triple Negative Breast Neoplasms
01/2022
1Disease Progression
11/2021
1Brain Neoplasms (Brain Tumor)
10/2021
1COVID-19
05/2021
1Adenocarcinoma of Lung
01/2021
1Basal Cell Carcinoma (Rodent Ulcer)
01/2020

Drug/Important Bio-Agent (IBA)

6Immune Checkpoint InhibitorsIBA
11/2023 - 08/2017
3IpilimumabIBA
10/2021 - 01/2017
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2023 - 01/2017
2Proteins (Proteins, Gene)FDA Link
11/2023 - 08/2019
2B7-H1 AntigenIBA
01/2022 - 01/2017
2pembrolizumabIBA
01/2022 - 08/2017
2Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2017
1ChromatinIBA
04/2024
1Angiogenesis InhibitorsIBA
11/2023
1Circulating Tumor DNAIBA
01/2022
1atezolizumabIBA
01/2022
1GlucocorticoidsIBA
11/2021
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
10/2021
1NivolumabIBA
10/2021
1TroponinIBA
05/2021
1AntigensIBA
01/2021
1birinapantIBA
01/2021
1Double-Stranded RNA (RNA, Double Stranded)IBA
01/2020
1X-Linked Inhibitor of Apoptosis ProteinIBA
08/2019
1SurvivinIBA
08/2019
1Peptide LibraryIBA
08/2019
1EpitopesIBA
08/2019
1Programmed Cell Death 1 ReceptorIBA
01/2017
1Bevacizumab (Avastin)FDA Link
01/2017
1CytokinesIBA
01/2017

Therapy/Procedure

10Therapeutics
01/2022 - 01/2017
3Immunotherapy
04/2024 - 01/2020
1Drug Therapy (Chemotherapy)
01/2022
1Aftercare (After-Treatment)
01/2020